Share This Article:

Safety and Antibody Responses to Aerosolized MMR II Vaccine in Adults: An Exploratory Study

Abstract Full-Text HTML Download Download as PDF (Size:155KB) PP. 55-60
DOI: 10.4236/wjv.2012.22008    4,305 Downloads   7,876 Views   Citations


Background: There have been no reported studies involving aerosol immunization with 2 of the 3 components of MMR II vaccine—Attenuvax measles vaccine and Jeryl-Lyn mumps vaccine. Objective: To evaluate the safety and antibody responses to aerosolized Attenuvax measles strain, Jeryl Lynn mumps strain and RA 27/3 rubella component of an MMR vaccine in adults, before assessing the booster administration of this vaccine in children. Methods: A pilot study to evaluate safety and antibody responses of MMR II (Merch Sharp & Dhome Corp., Whitehouse Station, NJ 08889, USA) components administered by aerosol was carried out in 27 healthy adults of 21 to 38 years of age. All participants were followed-up during 28 days following immunization for detection of clinical adverse events. Immune response was evaluated by plaque reduction neutralization test for measles, and commercial ELISA kits for rubella and mumps. Results: Only mild clinical adverse events were noted. Despite high levels of baseline seropositivity to all vaccine components, seroresponses to measles, rubella and mumps occurred in 44%, 15% and 41%, respectively. Conclusions: These outcomes compare favorably with earlier studies of other MMR vaccines given by aerosol. Further evaluations on safety and booster immune response should be performed in children.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

J. Diaz-Ortega, J. V. Bennett, D. Castaneda, D. Ma Arellano, D. Martinez and J. Fernandez de Castro, "Safety and Antibody Responses to Aerosolized MMR II Vaccine in Adults: An Exploratory Study," World Journal of Vaccines, Vol. 2 No. 2, 2012, pp. 55-60. doi: 10.4236/wjv.2012.22008.


[1] J. V. Bennett, J. Fernández de Castro, R. Martínez Poblete, M. L. Garcia-Alcantara, E. G. Diaz, M. A. M. Angeles, R. M. Wong-Chew, E. Arias-Toledo, C. Witham and J. I. Santos-Preciado, “A New Rapid, and Promising Approach to Aerosol Immunization: Inflatable Bags and Valved Masks,” Vaccine, Vol. 27, No. 34, 2009, pp. 4571-4575. doi:10.1016/j.vaccine.2009.05.086
[2] J. Fernández de Castro, J. V. Bennett, H. Gallardo-Rincon, M. T. Munoz, L. A. Sanchez and J. I. Santos, “Evaluation of Immunogenicity and Side Effects of Triple Viral Vaccine (MMR) in Adults, Given by Two Routes: Subcutaneous and Respiratory (Aerosol),” Vaccine, Vol. 23, No. 8, 2005, pp. 1079-1084. doi:10.1016/j.vaccine.2004.08.018
[3] J. L. Diaz-Ortega, J. V. Bennett, D. Castaneda, J. R. Vieyra, J. L. Valdespino-Gomez and J. Fernández de Castro, “Successful Seroresponses to Measles and Rubella Following Aerosolized Triviraten Vaccine, but Poor Response to Aerosolized Mumps (Rubini) Component: Comparisons with Injected MMR,” Vaccine, Vol. 28, No. 3, 2010, pp. 692-698. doi:10.1016/j.vaccine.2009.10.083
[4] J. L. Diaz-Ortega, J. V. Bennett, D. Castaneda, D. Martinez and J. Fernández de Castro, “Antibody Persistence in Young Adults 1 Year after MMR Immunization by Aerosol or by Subcutaneous Route,” Vaccine, Vol. 28, No. 44, 2010, pp. 7228-7232. doi:10.1016/j.vaccine.2010.08.055
[5] B. Bankamp, M. Takeda, Y. Zhang, W. Yu and P. Rota, “Genetic Characterization of Measles Vaccine Strains,” Journal of Infectious Diseases, Vol. 204, No. S1, 2011, pp. S533-S548. doi:10.1093/infdis/jir097
[6] A. Dilraj, F. Cutts, J. Fernandez de Castro, J. Wheeler, D. Brown, H. Coovadia and J. V. Bennett, “Response to Different Measles Vaccine Strains Given by Aerosol and Subcutaneous Routes to Schoolchildren: A Randomized Trial,” Lancet, Vol. 355, No. 9206, 2000, pp. 798-803. doi:10.1016/S0140-6736(99)95140-1
[7] A. M. Galazka, S. Robertson and A. Kraigher, “Mumps and Mumps Vaccine: A Global Review,” Bulletin of the World Health Organization, Vol. 77, No. 1, 1999, pp. 3-14.
[8] P. M. Strebel, M. J. Papania, G. H. Dayan and N. A. Halsey, “Measles Vaccine,” In: S. A. Plotkin, W. Orenstein and P. Offit, Eds., Vaccines, WB Saunders Elsevier, Philadelphia, 2008, pp. 353-398.
[9] S. A. Plotkin and S. E. Reef, “Rubella Vaccine,” In: S. A. Plotkin, W. Orenstein and P. Offit, Eds., Vaccines, WB Saunders Elsevier, Philadelphia, 2008, pp. 737-772.
[10] Biológicos y Reactivos de México, “MMR Vaccines Registered in Mexico,” 2008.
[11] Aerogen, “Aeroneb Go,” 2009.
[12] Vacumed, “1029 Disposable Cardboard Mouthpieces with One-way valve,” 2009.
[13] B. J. Cohen, S. Audet, N. Andrews, J. Beeler, WHO working group on measles plaque reduction neutralization test, “Plaque Reduction Neutralization Test for Measles Antibodies: Description of A Standardized Laboratory Method for Use in Immunogenicity Studies of Aerosol Vaccination,” Vaccine, Vol. 26, No. 1, 2007, pp. 59-66. doi:10.1016/j.vaccine.2007.10.046
[14] R. T. Chen, L. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud and W. A. Orenstein, “Measles Antibody: Reevaluation of Protective Titers,” Journal of Infectious Diseases, Vol. 162, No. 5, 1990, pp. 1036-1042. doi:10.1093/infdis/162.5.1036
[15] Behring, EnzygnostR Anti-Rubella-Virus/IgG, Manual de Instrucciones, 2004.
[16] Behring, EnzygnostR Anti Parotitis-Virus/IgG, Manual de Instrucciones, 2003.
[17] J. V. Bennett, J. Fernández de Castro, J. L. ValdespinoGomez, L. Garcia-Garcia, R. Islas-Romero, G. EchanizAviles, A. Jimenez-Corona and J. Sepulveda-Amor, “Aerosolized Measles and Measles-Rubella Vaccines Induce Better Measles Antibody Booster Responses than Injected Vaccines: Randomized Trials in Mexican Schoolchildren,” Bulletin of the World Health Organization, Vol. 80, No. 10, 2002, pp. 806-812.
[18] J. Bellanti, B. Zeligs, J. Mendez-Inocencio, L. Garcia-Garcia, R. Islas-Romero, B. Omidvar, J. Omidvar, G. Kim, J. Fernandez de Castro, J. Sepulveda-Amor, L. Walls, W. Bellini and J. L. Valdespino-Gomez, “Immunologic Studies of Specific Mucosal and Systemic Immune Responses in Mexican Schoolchildren After Booster Aerosol or Subcutaneous Immunization with Measles Vaccine,” Vaccine, Vol. 22, No. 9-10, 2004, pp. 1214-1220. doi:10.1016/j.vaccine.2003.09.032
[19] J. Sepulveda-Amor, J. L. Valdespino-Gomez, L. GarciaGarcia, J. V. Bennett, R. Islas-Romero, G. Echaniz-Aviles and J. Fernández de Castro, “A Randomized Trial Demonstrating Successful Boosting Responses Following Simultaneous Aerosols of Measles and Rubella (MR) Vaccines in Schoolchildren,” Vaccine, Vol. 20, No. 21-22, 2002, pp. 2790-2795. doi:10.1016/S0264-410X(02)00179-2

comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.